Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human Plasma

Lenalidomide, an immunomodulatory agent, and flavopiridol, a broad cyclin-dependent kinase inhibitor, are both active therapies for clinical use in genomic high risk chronic lymphocytic leukemia (CLL). A high-performance liquid chromatographic assay with tandem mass spectrometric detection has been...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, Qing, Farley, Katherine L., Johnson, Amy J., Muthusamy, Natarajan, Hofmeister, Craig C., Blum, Kristie A., Schaaf, Larry J., Grever, Michael R., Byrd, John C., Dalton, James T., Phelps, Mitch A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740534/
https://ncbi.nlm.nih.gov/pubmed/18708993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0b013e318185813d
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados